The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 11, 2018

Filed:

Jul. 10, 2015
Applicant:

Synaptamine, Inc., Austin, TX (US);

Inventor:

Kenneth Blum, Austin, TX (US);

Assignee:

IGENE LLC, Austin, TX (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G06F 19/00 (2018.01); C12Q 1/6827 (2018.01); G16H 50/30 (2018.01); C12Q 1/6883 (2018.01); G06F 19/20 (2011.01); G06F 19/22 (2011.01); G06F 19/24 (2011.01); G06F 19/18 (2011.01);
U.S. Cl.
CPC ...
C12Q 1/6827 (2013.01); C12Q 1/6883 (2013.01); G06F 19/00 (2013.01); G06F 19/18 (2013.01); G06F 19/20 (2013.01); G06F 19/22 (2013.01); G06F 19/24 (2013.01); G16H 50/30 (2018.01); C12Q 2537/165 (2013.01); C12Q 2600/124 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/16 (2013.01);
Abstract

Methods and kits for assessing severity index for alcohol abuse, drug abuse, and other reward deficiency syndromes. It has been discovered that a multifaceted non-specific RDS behaviors should be considered as the true 'reward' phenotype (endophenotype) instead of a single subset RDS behavior such as alcoholism. In an embodiment of the present invention, it has been discovered that there are at least eleven risk alleles associated with ten candidate genes. The methods and kits of the present invention satisfy the need to classify patients at genetic risk for drug/alcohol seeking behavior prior to or upon entry to residential and or non-residential chemical dependency and pain programs.


Find Patent Forward Citations

Loading…